Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy care continuum communication

	Profile	Recent Articles on Subject
1	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Spravato is just the beginning in a new wave of depression meds - 6 days ago Neuro drugs are still faltering, despite rising investment - 4 months ago
2	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Drugmaker shut down after black schmutz found in injectable weight-loss drug - 13 days ago Buying shady weight loss drugs online is a bad idea, in case you were wondering - 4 months ago
3	Vox Staff Vox World explained. techdigital cultureentertainment	Welcome to the Drug Issue of The Highlight - 13 days ago
4	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	More evidence on GLP-1s and opioid addiction - about 1 month ago Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch - 11 months ago STAT+: Even as Wegovy rides high, interest surges in weight loss drugs that preserve muscle - about 1 year ago
5	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 2 months ago
6	Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	What to Know About Delta-8 and Other Common Vape Shop Drugs - 2 months ago More people die after smoking drugs than injecting them, study finds - 9 months ago
7	Flora Graham Nature Writes Nature Briefing. Tweets own. On B’sky. London, United Kingdom science	Daily briefing: Deepfakes hawk fake drugs using scientists’ faces - 3 months ago
8	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about FDA rejecting MDMA; a nasal spray for allergic reactions, and more - 3 months ago STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - 8 months ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - 9 months ago STAT+: Pharmalittle: We’re reading about a pharma job slowdown, diet drugs boosting GDP, and more - 9 months ago STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more - 9 months ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - 11 months ago STAT+: Pharmalittle: Employers hire virtual providers as obesity drug gatekeepers; Vertex non-opioid nerve pain drug succeeds in mid-stage trial - 11 months ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - about 1 year ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - about 1 year ago
9	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	A tough week for MDMA-assisted psychotherapy - 3 months ago FDA rejects MDMA as a psychedelic treatment for PTSD - 3 months ago Psychedelic investment continues to ramp up - 9 months ago
10	Emily Mullin Wired Staff writer at WIRED. Covers biotechnology. Fall 2021 fellow. Pittsburgh, Pennsylvania biotechnology	The FDA Just Rejected a Bid for MDMA to Treat PTSD - 3 months ago

Journalists covering drugs